Cancer-derived iPSc

 

 

Celther Polska offers iPS cells generated from cells obtained from patients with prostate or breast cancer.

CLTH/iPSc-breast-cancer and CLTH/iPSc-prostate-cancer were established through reprogramming of

cells derived from patients diagnosed with prostate or breast cancer.

These cells display pluripotency markers (TRA-1-60, TRA-1-81, NANOG, alkaline phosphatase activity).

 

 

There are two types.

• CLTH/iPSc-breast cancer

• CLTH/iPSc-prostate cancer

    

   

Form:

 

Frozen

Species:

 

Human

Culture type:

 

Adherent Cell Culture

Donor source:

 

Single donor

Number of cells:

 

30 colonies

Tests Performed:

 

Sterility Testing (Bacteria & Fungi)

  

 

Ordering information;

    

Catalog No.

Product Name

Size

CL 05018-BC-CLTH

CLTH/iPSc-breast cancer

1 vial

CL 05018-PC-CLTH

CLTH/iPSc-prostate cancer

1 vial